Elevance Health Inc. (ELV) Tops Q1 EPS by 15c

Elevance Health Inc. (NYSE: ELV) reported Q1 EPS of $9.46, $0.15 better than the analyst estimate of $9.31. Revenue for the quarter came in at $41.9 billion versus the consensus estimate of $40.92 billion.

For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Ross Stores, Inc. (ROST) PT Raised to $240 at Bernstein SocGen Group
• ZKH Group Limited (ZKH) Reports Q2 EPS of $0.04